China is in talks with the World Health Organization to have its locally produced vaccines included in the “emergency use listing,” a WHO official said Tuesday.

“At this point, China has already approached WHO on preliminary discussion whereby China may participate in the Emergency Use Listing [EUL] of these vaccines. And potentially through this Emergency Use Listing the quality and safety of the vaccine and efficacy could be assessed in a facilitated way and then this could be made available for our licensing in countries,” said Socorro Escalate of the WHO.
“The goal of WHO is to ensure all countries will have access to the earliest vaccines that are proven to be safe, effective, and good quality in the market. The last point for China, their willingness to discuss with WHO on the potential for EUL or the Emergency Use Listing is a very good indication of the solidarity again in this region,” added Escalate.

According to WHO, the Emergency Use Listing is a “risk-based procedure for assessing and listing unlicensed vaccines, therapeutics and in vitro diagnostics with the ultimate aim of expediting the availability of these products to people affected by a public health emergency.”

In order for a vaccine to be submitted to the Emergency Use Listing, manufacturers must supply manufacturing quality data, non-clinical data, and clinical data to the WHO, as well as a plan to monitor quality, safety, and efficacy in the field and an undertaking to submit any new data to WHO as soon as the new data are available.



Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.